Forget Bitcoin: 3 Cryptocurrency Stocks Below $10

Bitcoin continues to grow, but other cryptocurrency stocks are coming up on its tail. Luckily, some of these trade at the low price of $10 or under!

| More on:

If you’re a Canadian investor, then it’s likely you have a Tax-Free Savings Account (TFSA). While the TFSA is great, this year there is a total contribution room of $75,500. Now, if you’re interested in buying Bitcoin, you have a problem. Bitcoin currently trades at around $66,600 as of writing. So, even if you haven’t invested a penny into your TFSA, it means you can only put one solitary Bitcoin in your TFSA. Maybe it’s time to look at the bigger picture of cryptocurrency.

Let’s say you don’t have $66,600 lying around. But you want to get in on the cryptocurrency action. I don’t blame you! Luckily, there are other ways to invest in Bitcoin and cryptocurrency that won’t cost thousands. In fact, you can keep it all under $10 per share.

The Bitcoin ETF

Canada now has several exchange-traded funds (ETF) exclusively focused on Bitcoin. The first official one was Purpose Bitcoin ETF (TSX:BTCC.B). It invests 100% into Bitcoin, using funds from investors to buy up Bitcoin, and then ETF investors get a share. So, basically, it’s like investing in Bitcoin for a fraction of the price. As you can see, the stock has performed almost exactly like Bitcoin since coming on the market.

As of writing, Purpose ETF has about $1.2 billion worth of Bitcoin on hand. Shares in the ETF are up 13% since coming on the market this year. If you’re one to believe that Bitcoin not only has a future but one that’s set to skyrocket, then Purpose is exactly what you want. Right now, you can pick up shares for about $10.25.

Bigger than Bitcoin?

Dogecoin has been exploding this year, though not by share price. Let’s do another side-by-side comparison to Bitcoin. While Bitcoin is currently up 545% in the last year, Dogecoin is up an insane 23,430% in the last year! That growth, of course, needs to be taken into context. While Bitcoin has been trading in the tens of thousands, Dogecoin went from $0.0034 per share to $0.80 per share. Yes, you could have made millions, but that would have been a rare occurrence.

The question is, can you still make millions? The cryptocurrency, which started out as a joke, is just like any other cryptocurrency stock. The entire market is volatile, so you’re likely to see massive fluctuation from this investment. That’s especially since a one-cent move could be a huge dent if you invest enough to make millions. So, this isn’t my favourite, but at $0.80 per share, it’s absolutely affordable to take a small stake.

HIVE stock

This is, by far, my favourite investment. Whether you’re interested in Dogecoin, Bitcoin, Ethereum, or any other cryptocurrency, HIVE Blockchain Technologies (TSXV:HIVE) is what you’ll need. The company invests in climate-controlled data centres to mine and sell cryptocurrency. It continues to grow through acquisition and is an actual business, not a currency.

What this means is, its performance is actually dependent on revenue. Most recently, that revenue increased to $13 million, up from $5 million the same time last year. And the stock keeps on rising. As of writing, shares in HIVE stock trade at $4.22 per share and are up 1,123% in the last year lone! So, here you get the middle ground in performance between the craziness of Dogecoin and stability of Purpose.

Bottom line

Cryptocurrency remains an area of investment with lots of volatility. While all three of these stocks trade under $12 per share, if you’re going to consider one, I would go with HIVE stock. The others are too dependent on the performance of an individual currency. HIVE stock, however, just depends on whether cryptocurrency will be around years from now. If today is any indicator, it looks like a likely future.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned.

More on Tech Stocks

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

profit rises over time
Tech Stocks

2 Non-AI Tech Stocks to Buy in November for Better Returns

Not all AI stocks are riding the hype train, and for many investors, well-understood and predictable growth stocks might be…

Read more »

worry concern
Tech Stocks

In a Few Years, You’ll Probably Regret Not Owning BlackBerry Stock

Here’s why I believe BlackBerry could be one of the most overlooked Canadian tech stocks right now.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

Is Constellation Software Stock a Buy for its 0.25% Dividend Yield?

Here's what investors may want to consider when it comes to Dollarama (TSX:DOL) and its relatively low dividend yield.

Read more »

Nurse talks with a teenager about medication
Tech Stocks

Shares of WELL Health Just Zoomed. Is It a Buy?

Given its improving financials and healthy growth prospects, WELL Health could deliver superior returns over the next three years.

Read more »